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The Ministry of Health of Saudi Arabia has issued
the following requirements and recommendations
for entry visas for the year 1431H (2010) Hajj and
Umra seasons.
I. Yellow fever
(A) In accordance with the revised International
Health Regulations (1) 2005, all travellers arriving
from countries or areas at risk of yellow fever trans-
mission (list of countries below) must present a
valid yellow fever vaccination certiﬁcate showing
that the person was vaccinated at least 10 days pre-
viously and not more than 10 years before arrival at
the border.
In the absence of such a certiﬁcate, the individ-
ual will be placed under strict surveillance for 6
days from the date of vaccination or the last date
of potential exposure to infection, whichever is
earlier. Health ofﬁces at entry points will be respon-
sible for notifying the appropriate Director General
of Health Affairs in the region or governorate about
the temporary place of residence of the visitor.
The following countries/areas are at risk of
yellow fever transmission (as deﬁned by the Inter-
national travel and health):
Africa: Angola, Benin, Burkina Faso, Burundi,
Cameroon, Central African Republic, Chad, Congo,
Côte d’Ivoire, Democratic Republic of Congo, Equa-
torial Guinea, Ethiopia, Gabon, Gambia, Ghana,
Guinea, Guinea-Bissau, Kenya, Liberia, Mali, Mau-
ritania, Niger, Nigeria, Rwanda, Sao Tome and
Principe, Senegal, Sierra Leone, Somalia, Sudan,
Togo, Uganda and United Republic of Tanzania.
 This report will appear in WHO publication WER issue no. 43,
Volume 85, scheduled for release October 22nd Year 2010.
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Americas: Argentina, Bolivia, Brazil, Colom-
ia, Ecuador, French Guyana, Guyana, Panama,
araguay, Peru, Suriname, Trinidad and Tobago and
enezuela.
(B) Aircraft, ships and other means of transporta-
ion arriving from areas infected with yellow fever
re requested to submit a certiﬁcate indicating that
t applied disinsection in accordance with methods
ecommended by WHO.
In accordance with the International Health Reg-
lations (2005), all arriving ships will be requested
o provide to the competent authority a valid Ship
anitation Certiﬁcate. Ships arriving from areas
t risk for yellow fever transmission may also be
equired to submit to inspection to ensure they are
ree of yellow fever vectors, or disinsected, as a
ondition of granting free pratique (including per-
ission to enter a port, to embark or disembark and
o discharge or load cargo or stores).
I. Meningococcal meningitis
A) For all arrivals: Visitors from all over the world
rriving for the purpose of ‘‘Umra’’ or pilgrim-
ge or for seasonal work are required to produce
certiﬁcate of vaccination with the quadrivalent
ACYW135) vaccine against meningitis issued not
ore than 3 years previously and not less than 10
ays before arrival in Saudi Arabia. The responsible
uthorities in the visitor’s country of origin should
nsure that adults and children over the age of 2
ears are given 1 dose of the quadrivalent polysac-
haride (ACYW135) vaccine.
(B) Arrivals from countries of the African menin-
itis belt, namely Benin, Burkina Faso, Cameroon,
had, Central African Republic, Côte d’Ivoire,
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ritrea, Ethiopia, Gambia, Guinea, Guinea-Bissau,
ali, Niger, Nigeria, Senegal and Sudan.
In addition to the above stated requirements,
hemoprophylaxis will be administered at port of
ntry to all arrivals from these countries to lower
he carriers rate among them. Adults will receive
iproﬂoxacin tablets (500mg); children will receive
ifampicin, and pregnant women will receive ceftri-
xone injections.
(C) Interior pilgrims and the Hajj workers: Vac-
ination with quadrivalent (ACYW135) vaccine is
equired for:
all citizens and residents of Madina and Makkah
who have not been vaccinated during the past 3
years;
all citizens and residents undertaking the Hajj;
all Hajj workers who have not been vaccinated
in the past 3 years;
any individual working at entry points or in direct
contact with pilgrims in Saudi Arabia.
II. Poliomyelitis
A) All visitors age under 15 years travelling
o Saudi Arabia from countries reinfected with
oliomyelitis (list below) should be vaccinated
gainst poliomyelitis with the oral polio vaccine
OPV). Proof of OPV vaccination is required 6 weeks
rior the application for entry visa. Irrespective of
revious immunization history, all visitors under 15
ears arriving in Saudi Arabia will also receive a
ose of OPV at border points.
The following countries are considered to be
einfected with poliomyelitis (as of 10th of Septem-
er 2010).
Angola, Cameroon, Benin, Burkina Faso, Burundi,
had, Côte d’Ivoire, Democratic Republic of the
ongo, Central African Republic, Guinea, Kenya,
iberia, Mali, Mauritania, Nepal, Niger, Russian Fed-
ration, Senegal, Sierra Leone, Sudan, Tajikistan,
ogo, Turkmenistan, Uganda, Uzbekistan.
(B) All travellers from Afghanistan, India, Nige-
ia and Pakistan: Regardless of age and vaccination
tatus, should receive 1 dose of OPV. Proof of OPV
accination at least 6 weeks prior departure is
equired to apply for entry visa for Saudi Arabia.
hese travellers will also receive a dose of OPV at
orders points when arriving in Saudi Arabia.V. Inﬂuenza vaccination
fter the declaration by WHO that the world is no
onger in phase 6 inﬂuenza H1N1 pandemic alert,
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he Ministry of Health of Saudi Arabia recommends
hat international pilgrims be vaccinated against
easonal inﬂuenza before arrival into the kingdom
f Saudi Arabia with WHO approved strains speciﬁc
o the Northern or Southern hemispheres, partic-
larly those with pre-existing conditions (e.g. the
lderly, people with chronic chest or heart diseases
r cardiac, hepatic or renal failure). In KSA sea-
onal inﬂuenza vaccine is recommended for internal
ilgrims particularly those with pre-existing condi-
ions and all HCW’s working in the hajj premises.
. Food
isitors and pilgrims are not allowed to bring fresh
ood into the country. Only properly canned food is
llowed in a small amount enough for one person
or the duration of his or her trip.
I. International outbreaks response
A) All pilgrims arriving at entry points in Saudi
rabia for the Hajj or Umra will be screened for
ymptoms of speciﬁc diseases of concern such as
engue fever, meningococcal meningitis, measles
nd yellow fever. Suspect cases will be isolated and
irect contacts placed on observation.
(B) updating immunization against vaccine pre-
entable diseases like tetanus and diphtheria (Td)
n all travellers is strongly recommended. With
he recent resurgence of measles cases, special
ttention is needed to avoid widespread outbreaks
ith this virus during this year Umra and Hajj.
hile WHO travel advice regarding measles remains
nchanged, preparation for international travel
ay be an opportunity to review the immuniza-
ion status of travellers. Incompletely immunized
ravellers can be offered routine vaccinations rec-
mmended in national immunization schedules
these usually include diphtheria, tetanus, pertus-
is, polio, measles, and mumps), in addition to
hose needed for the speciﬁc travel (e.g. meningo-
occal vaccination for Hajj). IN chapter 6 of the
‘International Travel and Health’’ — 2010 publi-
ation [1] WHO recommends that travellers ensure
mmunity against measles by at least two doses of
accine before travel.
(C) In the event of health emergency causingnternational health concern or in case of outbreaks
ubjective to international health regulations in any
ountry from where the pilgrims and Umra perfor-
ance come the Saudi Arabia Health Authorities
ay take any additional preventive precautions
Tel.: +966 12124052; fax: +966 12125052.94
(not included in the measures mentioned above)
after consultation with the WHO to avoid the spread
of infection among pilgrims and Umra performance
or the diffusion to their countries.Reference
[1] WHO. International Travel and Health — 2010
(www.who.int/ith).
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